Ameritas Advisory Services’s AbbVie ABBV Stock Holding History

Ameritas Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.25M	Buy	32,773 +15,587	+91%	+$3.35M	0.17%	121
2026 Q1	$3.74M	Buy	17,186 +417	+2%	+$92.5K	0.14%	139
2025 Q4	$3.83M	Buy	16,769 +498	+3%	+$113K	0.14%	137
2025 Q3	$3.77M	Buy	16,271 +3,830	+31%	+$780K	0.25%	82
2025 Q2	$2.31M	Sell	12,441 -9,874	-44%	-$1.84M	0.12%	170
2025 Q1	$4.27M	Sell	22,315 -1,621	-7%	-$315K	0.17%	130
2024 Q4	$4.25M	Buy	23,936 +3,657	+18%	+$672K	0.15%	135
2024 Q3	$4M	Sell	20,279 -3,979	-16%	-$743K	0.17%	129
2024 Q2	$4.16M	Sell	24,258 -2,013	-8%	-$333K	0.16%	132
2024 Q1	$4.49M	Buy	26,271 +7,280	+38%	+$1.25M	0.19%	105
2023 Q4	$3.15M	Sell	18,991 -8,626	-31%	-$1.26M	0.17%	118
2023 Q3	$4.12M	Buy	27,617 +16,362	+145%	+$2.4M	0.21%	99
2023 Q2	$1.53M	Sell	11,255 -13,614	-55%	-$2M	0.2%	120
2023 Q1	$4.03M	Sell	24,869 -7,557	-23%	-$1.16M	0.2%	98
2022 Q4	$5.24M	Buy	32,426 +3,550	+12%	+$544K	0.24%	97
2022 Q3	$3.88M	Buy	28,876 +86	+0.3%	+$12.3K	0.23%	93
2022 Q2	$4.41M	Buy	28,790 +2,490	+9%	+$380K	0.26%	84
2022 Q1	$4.26M	Buy	26,300 +1,215	+5%	+$176K	0.16%	99
2021 Q4	$3.4M	Buy	+25,085	New	+$2.96M	0.12%	142

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameritas Advisory Services's ABBV Position: Q2 2026 in Review

Ameritas Advisory Services increased its AbbVie (ABBV) stake by 91% in Q2 2026, buying an estimated $3.35M and bringing the position to 32,773 shares worth $8.25M. The position accounts for 0.17% of the portfolio, ranked #121.

Ameritas Advisory Services first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ameritas Advisory Services held 32,773 shares of AbbVie worth $8.25M as of Q2 2026.
Ameritas Advisory Services bought 15,587 AbbVie shares in Q2 2026, an estimated $3.35M.
AbbVie made up 0.17% of Ameritas Advisory Services's portfolio in Q2 2026, its #121 holding.
Ameritas Advisory Services first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.